Wikidata

(Q64348382)

English

Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)

clinical trial

In more languages

Statements

title
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Belarus
0 references
Belgium
0 references
Bosnia and Herzegovina
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Georgia
0 references
Greece
0 references
Hungary
0 references
Italy
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Ukraine
0 references
United Kingdom
0 references
start time
3 December 2013
0 references
end time
27 March 2017
0 references
number of participants
1,320
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64348382&oldid=2093930077"